Medivir AB (STO:MVIRB), Stockholm, Sweden, has signed two new pharmaceutical
license agreements and an extension of the ongoing research collaboration in hepatitis C (HCV) with Tibotec Pharmaceuticals Ltd.
While such a general legal difference exists, the fact is, telecommunications
license agreements fail many, if not all, of the tests that differentiate leases from
license agreements.
These
license agreements explicitly deny many rights defined by the copyright laws and have introduced new issues of user identity, product capabilities, and restrictions on use into the selection decision.
com/reports/c50264) has announced the addition of Structuring Patent Licensing Transactions: Leading Lawyers on Structuring Terms, Negotiating
License Agreements and Closing Deals (Inside the Minds) to their offering.
Spansion joins a growing list of semiconductor suppliers and system manufacturers who have signed patent
license agreements for various products covered by Rambus patents.
Many of these companies simply do not have the resources -- both financial and human -- to interpret software
license agreements and establish very costly compliance initiatives, largely because of the unnecessary complexities of the
license agreements created by the software industry.
After these patent
license agreements were signed, InterDigital notified Nokia and Samsung of their royalty payment obligations.
Nasdaq:GILD) today announced that the company has signed non-exclusive
license agreements to provide generic versions of tenofovir disoproxil fumarate (sold by Gilead under the brand name Viread(R)) to three generic manufacturers in India.
The terms of the settlement and
license agreements have been finalized, and the settlement is conditioned upon the entry of orders vacating certain orders and judgments in the U.
No technology rights are included in these agreements and any projects developed will be developed under standard
license agreements.
STOCKHOLM, Sweden -- Medivir AB (STO:MVIRB) announced today the signing of two new pharmaceutical
license agreements and an extension of the ongoing research collaboration in hepatitis C (HCV) with Tibotec Pharmaceuticals Ltd.
Evidence of this can be seen with ESPRE's recently signed
license agreements and the deployment of several new customer initiatives.
